TMPIT Activators encompass a diverse array of chemical compounds that indirectly augment TMPIT's functional activity via multiple signaling pathways. Forskolin and IBMX, through elevation of intracellular cAMP levels, indirectly foster TMPIT activation by stimulating PKA, a kinase that can phosphorylate TMPIT. Similarly, PMA activates PKC, which may phosphorylate TMPIT within certain cellular contexts, enhancing its activity. Increased intracellular calcium levels, triggered by Ionomycin and A23187, can activate calcium-dependent kinases that may phosphorylate TMPIT. Okadaic acid, by inhibiting protein phosphatases PP1 and PP2A, prevents TMPIT dephosphorylation, thus maintaining its active state. Sphingosine-1-phosphate, through its receptor-mediated signaling, initiates a cascade that can lead to kinase activation and subsequent phosphorylation of TMPIT.
The influence on TMPIT activity continues with compounds that modulate kinase signaling. Epigallocatechin gallate, by inhibiting certain kinases, may redirect phosphorylation events toward TMPIT. By inhibiting PI3K, LY294002 can potentially enhance TMPIT activity by altering AKT pathway signaling and fostering compensatory activation of TMPIT. U0126, a MEK1/2 inhibitor, may also reroute signaling to favor TMPIT activation. Further, 8-Br-cAMP serves as a cAMP analog which activates PKA, a kinase that could phosphorylate and activate TMPIT. Thapsigargin, by inhibiting SERCA, leads to a rise in cytosolic calcium, which could activate TMPIT through calcium-dependent signaling pathways. Collectively, these chemical activators, by targeting specific signaling mechanisms, facilitate the functional activation of TMPIT without directly increasing its expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing cAMP levels which can lead to activation of PKA. PKA can then phosphorylate various proteins including TMPIT, leading to its activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases which increases intracellular cAMP levels by preventing its breakdown. Elevated cAMP can enhance PKA activity, potentially leading to increased phosphorylation and activation of TMPIT. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC) which can phosphorylate and thus activate a multitude of proteins, including TMPIT, depending on the cell context. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases that may phosphorylate and activate TMPIT. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, which could enhance TMPIT activity due to reduced dephosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent signaling pathways that could result in TMPIT activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to downstream protein kinase activation and potentially enhance TMPIT activity through phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a kinase inhibitor that, by inhibiting competitive signaling pathways, may indirectly increase the availability of kinases to phosphorylate and activate TMPIT. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream AKT signaling, possibly leading to a shift in cellular signaling dynamics that enhances TMPIT activity through compensatory mechanisms. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2 that may shift the balance of cellular signaling towards pathways that include activation of TMPIT. | ||||||